Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24031958 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Oscar Zaragoza-García und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemical-Biological Sciences, Autonomous University of Guerrero, Chilpancingo 39087, Mexico. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid, Gastrointestinal Microbiome, Lactobacillus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intestinal dysbiosis is related to the physiopathology and clinical manifestation of rheumatoid arthritis (RA) and the response to pharmacologic treatment. The objectives of this study were (1) to analyze the effect of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) on the abundance of gut microbiota’s bacteria; (2) to evaluate the relationship between the differences in microbial abundance with the serum levels of intestinal fatty-acid binding protein 2 (IFABP2), cytokines, and the response phenotype to csDMARDs therapy in RA. A cross-sectional study was conducted on 23 women diagnosed with RA. The abundance of bacteria in gut microbiota was determined with qPCR. The ELISA technique determined serum levels of IFABP2, TNF-α, IL-10, and IL-17A. We found that the accumulated dose of methotrexate or prednisone is negatively associated with the abundance of Lactobacillus but positively associated with the abundance of Bacteroides fragilis. The Lactobacillus/Porphyromonas gingivalis ratio was associated with the Disease Activity Score-28 for RA with Erythrocyte Sedimentation Rate (DAS28-ESR) (r = 0.778, p = 0.030) and with the levels of IL-17A (r = 0.785, p = 0.027) in the group treated with csDMARD. Moreover, a relation between the serum levels of IFABP2 and TNF-α (r = 0.593, p = 0.035) was observed in the group treated with csDMARD. The serum levels of IFABP2 were higher in patients with secondary non-response to csDMARDs therapy. In conclusion, our results suggest that the ratios of gut microbiota’s bacteria and intestinal permeability seems to establish the preamble for therapeutic secondary non-response in RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemical-Biological Sciences, Autonomous University of Guerrero, Chilpancingo 39087, Mexico.
- HLA Laboratory, National Institute of Respiratory Diseases Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Infectious Diseases Research Center, National Institute of Respiratory Diseases Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Department of Medical Internal, General Hospital Raymundo Abarca Alarcón, Chilpancingo 39019, Mexico.
- Bacterial Metagenomics Laboratory, Faculty of Chemistry and Biology, University of Santiago of Chile, Santiago 8320000, Chile.
ORCID-Profile: Oscar Zaragoza-García, Gloria Pérez-Rubio, Ramcés Falfán-Valencia, Mario Tello, Iris Paola Guzmán-Guzmán
Zitieren
APA
Zaragoza-García, O., Castro-Alarcón, N., Pérez-Rubio, G., Falfán-Valencia, R., Briceño, O., Navarro-Zarza, J. E., Parra-Rojas, I., Tello, M., & Guzmán-Guzmán, I. P. (2023). Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24031958
Vancouver
Zaragoza-García O, Castro-Alarcón N, Pérez-Rubio G, Falfán-Valencia R, Briceño O, Navarro-Zarza JE, et al. Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24031958
BibTeX
@article{ZaragozaGarca2023,
author = {Zaragoza-García, Oscar and Castro-Alarcón, Natividad and Pérez-Rubio, Gloria and Falfán-Valencia, Ramcés and Briceño, Olivia and Navarro-Zarza, José Eduardo and Parra-Rojas, Isela and Tello, Mario and Guzmán-Guzmán, Iris Paola},
title = {Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24031958}
}
EUVIMED